capsaicin has been researched along with gw406381x in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beswick, PJ; Bingham, S; Bountra, C; Brown, T; Campbell, IB; Chessell, IP; Clayton, N; Collins, SD; Davey, PT; Goodland, H; Gray, N; Haslam, C; Hatcher, JP; Hunter, AJ; Lucas, F; Murkitt, G; Naylor, A; Pickup, E; Sargent, B; Stevens, A; Stratton, SC; Summerfield, SG; Wiseman, J | 1 |
1 other study(ies) available for capsaicin and gw406381x
Article | Year |
---|---|
The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization.
Topics: Animals; Brain; Capsaicin; COS Cells; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Hydrocarbons, Aromatic; Hyperalgesia; Male; Mice; Nitrogen; Pain; Pyrazoles; Pyridazines; Rats | 2005 |